Potential Use of Thalidomide in Glioblastoma Treatment: An Updated Brief Overview

Glioblastoma is the most common malignant primary brain tumor in adults. Thalidomide is a vascular endothelial growth factor inhibitor that demonstrates antiangiogenic activity, and may provide additive or synergistic anti-tumor effects when co-administered with other antiangiogenic medications. Thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Eatmann, Ahmed Ismail, Hamouda, Esraa, Hamouda, Heba, Farouk, Hossam Khaled, Jobran, Afnan W. M., Omar, Abdallah A., Madeeh, Alyaa Khaled, Al-dardery, Nada Mostafa, Elnoamany, Salma, Abd-Elnasser, Eman Gamal, Koraiem, Abdullah Muhammed, Ahmed, Alhassan Ali, Abouzid, Mohamed, Karaźniewicz-Łada, Marta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10146416/
https://www.ncbi.nlm.nih.gov/pubmed/37110201
http://dx.doi.org/10.3390/metabo13040543

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10146416/
https://www.ncbi.nlm.nih.gov/pubmed/37110201
http://dx.doi.org/10.3390/metabo13040543

Ejemplares similares